采纳股份：预计2025年净利润同比下降88.70%-92.47%

Core Viewpoint - The company expects a significant decline in net profit for the fiscal year 2025, projecting a range of 4 million to 6 million yuan, which represents a year-on-year decrease of 88.70% to 92.47% [1] Group 1 - The decline in net profit is attributed to ongoing impacts from the U.S. Food and Drug Administration (FDA) import warnings and increased tariffs imposed by the U.S. [1] - Changes in the company's product sales structure have occurred as a result of these external factors, leading to a decrease in the overall gross profit margin of the products [1]